| Primary |
| Salivary Hypersecretion |
21.0% |
| Motion Sickness |
14.5% |
| Parkinson's Disease |
9.7% |
| Mental Disorder |
8.1% |
| Smoking Cessation Therapy |
8.1% |
| Dysphagia |
6.5% |
| Increased Bronchial Secretion |
4.8% |
| Decreased Appetite |
3.2% |
| Drooling |
3.2% |
| Increased Upper Airway Secretion |
3.2% |
| Insomnia |
3.2% |
| Oesophagitis |
3.2% |
| Depression |
1.6% |
| Epilepsy |
1.6% |
| Jaw Disorder |
1.6% |
| Pneumonia Aspiration |
1.6% |
| Prophylaxis Against Motion Sickness |
1.6% |
| Vertigo |
1.6% |
| Vomiting |
1.6% |
|
| Wrong Technique In Drug Usage Process |
17.1% |
| Vomiting |
12.2% |
| Overdose |
9.8% |
| Skin Reaction |
7.3% |
| Therapeutic Response Unexpected |
7.3% |
| Stress |
4.9% |
| Thrombocytopenia |
4.9% |
| Transient Ischaemic Attack |
4.9% |
| Visual Impairment |
4.9% |
| Feeling Abnormal |
2.4% |
| Gait Disturbance |
2.4% |
| Malaise |
2.4% |
| Priapism |
2.4% |
| Respiratory Failure |
2.4% |
| Serum Ferritin Increased |
2.4% |
| Skin Irritation |
2.4% |
| Speech Disorder |
2.4% |
| Squamous Cell Carcinoma |
2.4% |
| Suicide Attempt |
2.4% |
| Tachycardia |
2.4% |
|
| Secondary |
| Schizophrenia |
16.0% |
| Product Used For Unknown Indication |
14.6% |
| Drug Use For Unknown Indication |
13.2% |
| Blood Cholesterol Increased |
5.9% |
| Type 2 Diabetes Mellitus |
5.6% |
| Depression |
5.2% |
| Hypertension |
4.9% |
| Constipation |
4.2% |
| Vomiting |
3.8% |
| Salivary Hypersecretion |
3.5% |
| Abdominal Pain |
3.1% |
| Abdominal Pain Upper |
2.4% |
| Irritable Bowel Syndrome |
2.4% |
| Mood Altered |
2.4% |
| Schizophrenia, Paranoid Type |
2.4% |
| Smoking Cessation Therapy |
2.4% |
| Nausea |
2.1% |
| Pain |
2.1% |
| Anxiety |
1.7% |
| Extrapyramidal Disorder |
1.7% |
|
| White Blood Cell Count Increased |
23.8% |
| Weight Decreased |
12.7% |
| Tachycardia |
11.1% |
| Vomiting |
9.5% |
| Agitation |
4.8% |
| Anaphylactic Reaction |
3.2% |
| Chorea |
3.2% |
| General Physical Health Deterioration |
3.2% |
| Neutropenia |
3.2% |
| Neutrophil Count Decreased |
3.2% |
| Somnolence |
3.2% |
| Therapeutic Agent Toxicity |
3.2% |
| Thrombocytopenia |
3.2% |
| White Blood Cell Count Decreased |
3.2% |
| Abdominal Pain |
1.6% |
| Anticholinergic Syndrome |
1.6% |
| Application Site Pruritus |
1.6% |
| Dermatitis Allergic |
1.6% |
| Erythema Multiforme |
1.6% |
| Ileus |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.4% |
| Schizophrenia |
15.4% |
| Product Used For Unknown Indication |
11.3% |
| Salivary Hypersecretion |
5.5% |
| Constipation |
4.5% |
| Pain |
4.2% |
| Depression |
3.7% |
| Anxiety |
2.9% |
| Back Pain |
2.8% |
| Hypertension |
2.8% |
| Abdominal Pain |
2.4% |
| Gastric Cancer |
1.9% |
| Prophylaxis |
1.9% |
| Hiv Infection |
1.7% |
| Crohn's Disease |
1.4% |
| Acute Myeloid Leukaemia |
1.4% |
| Colorectal Cancer Metastatic |
1.3% |
| Affective Disorder |
1.2% |
| Myocardial Ischaemia |
1.2% |
| Rheumatoid Arthritis |
1.2% |
|
| Vomiting |
20.3% |
| White Blood Cell Count Increased |
10.1% |
| Tachycardia |
7.5% |
| White Blood Cell Count Decreased |
6.2% |
| Death |
5.7% |
| Multiple Drug Overdose |
4.8% |
| Weight Increased |
4.8% |
| Pneumonia |
4.4% |
| Pulmonary Embolism |
4.4% |
| Somnolence |
4.0% |
| Sinus Tachycardia |
3.5% |
| Neutropenia |
3.1% |
| Thrombocytopenia |
3.1% |
| Weight Decreased |
3.1% |
| Hepatitis C |
2.6% |
| Oedema Peripheral |
2.6% |
| Suicide Attempt |
2.6% |
| Syncope |
2.6% |
| Diarrhoea |
2.2% |
| Gastrointestinal Tube Insertion |
2.2% |
|
